Dr. Kevin Palka, M.D.
Claim this profileWashington University School of Medicine
Area of expertise
Squamous Cell Carcinoma
Kevin Palka, M.D. has run 6 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Head And Neck Squamous Cell Carcinoma
Kevin Palka, M.D. has run 5 trials for Head and Neck Squamous Cell Carcinoma. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Clinical Trials Kevin Palka, M.D. is currently running
CUE-101
for Throat Cancer
This trial tests a new treatment called CUE-101 to see if it is safe and effective for patients with a specific type of throat cancer. The treatment aims to boost the immune system before standard cancer therapy. Patients are newly diagnosed and have not yet received any other treatments.
Recruiting
1 award
Phase 2
Palbociclib + Cetuximab
for Head and Neck Cancer
This multicenter, open-label, randomized phase 3 trial will determine if palbociclib and cetuximab (Arm 1) improves overall survival (OS) in comparison to cetuximab monotherapy (Arm 2) in patients with CDKN2A-altered, HPV-unrelated recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who experienced disease progression on a PD-1/L1 inhibitor (given as monotherapy or in combination with other therapy).
Recruiting
2 awards
Phase 3
More about Kevin Palka, M.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Kevin Palka, M.D. has experience with
- Cetuximab
- Palbociclib
- Pembrolizumab
- Mitomycin-C
- Pegfilgrastim
- Cisplatin
Breakdown of trials Kevin Palka, M.D. has run
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin Palka, M.D. specialize in?
Kevin Palka, M.D. focuses on Squamous Cell Carcinoma and Head and Neck Squamous Cell Carcinoma. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are p16 positive.
Is Kevin Palka, M.D. currently recruiting for clinical trials?
Yes, Kevin Palka, M.D. is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Kevin Palka, M.D. has studied deeply?
Yes, Kevin Palka, M.D. has studied treatments such as Cetuximab, Palbociclib, Pembrolizumab.
What is the best way to schedule an appointment with Kevin Palka, M.D.?
Apply for one of the trials that Kevin Palka, M.D. is conducting.
What is the office address of Kevin Palka, M.D.?
The office of Kevin Palka, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.